RRMS Has Different Stages With Different Symptoms
Patients suffering from relapse remitting multiple sclerosis should make healthy lifestyle choices to help cope with the disease
Monday, April 5, 2021 - RRMS is a subset of multiple sclerosis characterized by having physical seizures, and muscle spasms followed by a period of remission. The seizures may become more profound over time, and the period of remission decrease in duration. Lemtrada attempts to stop the progression of this condition. According to HealthLine, about 85% of multiple sclerosis cases become RRMS. "MS is a chronic, progressive condition of the central nervous system (CNS) in which your immune system attacks myelin, the protective layer around nerve fibers. When myelin is damaged, it causes the nerves to become inflamed and makes it difficult for your brain to communicate with the rest of your body," according to HealthLine. Healthline tells readers that RRMS symptoms become progressively more severe and long-lasting with or without treatment. According to HL, the symptoms of RRMS include, "sensations of numbness or tingling, fatigue, feeling weak, muscle spasms or stiffness, problems with coordination or balance, issues with vision, such as double vision, blurry vision, or partial or complete of vision loss, heat sensitivity, bowel or bladder problems, cognitive changes, such as trouble with processing, learning, and organizing information, tingling or shock-like sensations when bending the neck forward (Lhermitte's sign)."
RRMS patients may be given Lemtrada as a drug of last resort after all other attempts at treating RRMS have been exhausted. Lemtrada is highly toxic and can cause a stroke or heart attack immediately when the drug is first infused by an IV drip. Lemtrada is administered in five consecutive daily sessions, one year apart. The patient should remain in the hospital during the procedure, close to emergency room staff and facilities. The late stages of RRMS include severe and life-altering symptoms. These symptoms include "fatigue, walking difficulties, bowel and bladder disturbances, vision problems, changes in brain function, changes in sexual function, pain and depression or mood swings," according to an article in Canadian Virtual Hospice. Lemtrada patients and their prescribing physician must read and sign a risk-benefit disclosure statement to ensure the patient is aware of the potentially life-threatening health consequences. RRMS patients who have experienced strokes or heart attacks and were not warned have filed Lemtrada Side Effect lawsuits.
HealthLine has looked into the probable causes of RRMS and has identified genetic and environmental factors as contributing to the development of the condition. Other contributing factors could be smoking, poor diet, and lingering viral infections. The symptoms of RRMS could be managed by making healthy lifestyle decisions. Eating a plant-based diet, quitting smoking or using alcohol or other drugs, avoiding stress, and exercising more are all positive changes one should attempt to make to help with coping with the disease.
Disease-modifying therapies (DMT) can also help with coping with RRMS and can be taken in different forms such as orally or with an injection. The objectives of DMT are to slow the progression of the symptoms of the disease. Stem Cell Therapy is also starting to show promise as an effective DMT.
More Recent Lemtrada Stroke Lawsuit News:
- Lemrtrada Risks Were Worth It For One Recent Patient | 4/14/2021
- The Shocking Types of Deaths Caused By Lemtrada | 4/9/2021
- Nurses Monitor Lemtrada (Alemtuzumab) Patients For Signs of Its Deadly Side Effects | 3/31/2021
- Lemtrada Can Cause Sudden Death And Many Other Health Issues | 3/8/2021
- Lemtrada May Slow the Progression of Relapse Remitting MS But with Potentially Severe Side Effects | 3/5/2021
No-Cost, No-Obligation Lemtrada Lawsuit Case Review If You or a Loved One Suffered from Lemtrada Stroke Complications
OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.